Cathy Friedman - Director at Lyell Immunopharma, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
LYEL on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Cathy Friedman since 23 Aug 2025

Reported holdings for Cathy Friedman in Lyell Immunopharma, Inc.

Form 4 holding Director

Lyell Immunopharma, Inc.

Security class
Option (right to buy)
Shares / value
130,000
Estimated value
Report date
14 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Cathy Friedman in Lyell Immunopharma, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .